arrow
A

Agnieszka Michael

Royal Surrey County Hospital
H指数:38
被引数:6,390

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1-3 prostate cancer

LDR BURST试验:一项随机对照试验,比较使用间隔凝胶治疗的低剂量率近距离放疗与极超分次放疗在剑桥预后分组1-3的前列腺癌男性患者中的副作用

2026-04-270
PRE
ICON9: International phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy

ICON9: 国际III期随机研究,旨在评估奥拉帕利联合西地尼布或奥拉帕利单药维持治疗在铂类化疗有效后复发的铂敏感卵巢癌患者中的疗效。

2024-09-010
PRE
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

通过多祖先全基因组发现187种新的风险变异来表征前列腺癌风险

2023-11-0928
OA
British Gynaecological Cancer Society Recommendations for Women With Gynecological Cancer Who Received Non-standard Care During the COVID-19 Pandemic
2022-03-010
OA
Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial
2021-03-0149
OAAI
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

前列腺癌的跨祖先全基因组关联荟萃分析确定了新的易感位点并为遗传风险预测提供了信息

2021-01-04287
OAAI